Mitra Clip

Did you know that mitral regurgitation, a heart valve disorder that causes backflow of blood, is the third most common type of valvular heart disease, and is mainly a disorder of older adults responsible for causing 0.88 million deaths daily?

Moreover, approximately 3 to 5% of the American population is affected by mitral valve prolapse. In another survey, the incidence and prevalence of mitral valve disease in the elderly population was around 40%, commonly in people aged 60-80 years.

The increasing prevalence of mitral valve disease globally in the elderly urges the need for authentic and reliable procedures that can treat mitral valve disorders with minimal risks, complications, and increased success rates.

Luckily, MitraClip is one of the clinically-proven, non-invasive, and authentic procedures to treat mitral valve disease, designed for the elderly and people who cannot undergo open heart surgery because of certain risks. MitraClip has over 16+ years of proven safety, and efficacy, and has treated around 100,000 patients with mitral valve disease successfully.

The advantages of the MitraClip procedure include shorter hospital stays, faster recovery time, and a minimally-invasive implantation technique that increases patient outcomes and compliance towards the treatment, especially for the elderly and high-risk patients.

In addition, MitraClip doesn’t require any heart-lung machine or cardiopulmonary bypass to support breathing or heart function during the procedure. It also doesn’t need to temporarily stop the heart for implantation and can be performed while the heart is functioning.

MitraClip Success Rates

  • From MitraClip implantation, 88% of patients experienced a reduction in the severity of mitral regurgitation disease.
  • 83% of patients reported a sustained improvement in their heart failure symptoms at 5 years from MitraClip.
  • More than 2.5X patients showed a greater improvement in their quality of life.
  • Only 2.7% in-hospital mortality rates were reported from MitraClip implantation with 92% acute procedural success.


The prevailing signs and symptoms of mitral valve disease include

  • Shortness of breath
  • Irregular or rapid heartbeat
  • Extreme fatigue

Also Read:Treatment Of Chest Pain

MitraClip implantation may be needed in patients whose mitral valve, a heart valve that prevents the backflow of blood, is not functioning or closing properly, leading to the backflow of blood. The procedure is used to implant a healthy valve in place of a diseased mitral valve. MitraClip implantation is commonly indicated for patients with degenerative or functional mitral regurgitation.

The cost of MitraClip implantation in India depends on several factors, including the expertise of the surgeon, the type and location of the clinic, and the overall health condition of the patient. At BeHeartHealthy, we offer reasonable costs for MitraClip implantation procedures done by our trained and expert cardiologists.

The MitraClip implantation procedure has demonstrated a high level of safety and efficacy in many patients, achieving a remarkable success rate of 95.8% in alleviating mitral regurgitation disease.

As the name suggests, mitral valve replacement is a procedure that replaces a diseased mitral valve with a healthy functional valve, while mitral valve repair is a minimally-invasive procedure that repairs a damaged valve by placing a healthy valve in the position of the diseased valve. Both procedures are indicated for treating a leaky valve or other mitral valve diseases.